EUVIMEDEUVIMED entdecken
Crossref

Intra-wound vancomycin powder is cost-saving in primary total hip and knee arthroplasty

Darius L Lameire, Neil Askew, Iqbal Multani, Graeme Hoit, Amir Khoshbin, Leo M Nherera, Amit Atrey

International Orthopaedics · 2025

DOI: 10.1007/s00264-025-06501-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Orthopaedics, 2025. Verfasst von Darius L Lameire und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedic Surgery, University of Toronto, Toronto, Canada. darius.lameire@mail.utoronto.ca. Hauptthemen laut MEDLINE: Vancomycin, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study seeks to explore whether intra-wound vancomycin powder (IVP) is a cost-effective adjunct to standard of care (SOC) in patients undergoing total joint arthroplasty (TJA) from a US payor perspective. METHODS: A decision-analytic model in the form of a decision tree was developed to compare the cost and outcomes of IVP with those of SOC in preventing periprosthetic joint infections (PJI) in TJA patients. The base case analysis assumes a hypothetical practice with an equal volume (50/50) of THA and TKA procedures in both the IVP + SOC and the SOC arm. Cost and clinical effectiveness data were obtained from published literature. Sensitivity and threshold analyses were used to estimate how changing inputs would impact the cost-effectiveness of IVP. RESULTS: Deterministic results found that in the base case model, IVP as an adjunct to SOC generates a cost saving of $260.38/patient. In scenario analysis, where THA and TKA procedures were separated, the estimated cost saving was $241.50/patient and $279.27/patient, respectively. Break-even analysis showed that the cost of IVP per patient would need to be $244.82-$282.59, or the PJI relative risk (RR) be approximately 0.99. Probabilistic analysis found IVP + SOC was cost-saving in 99.26% of the 10,000 iterations in the base case model. CONCLUSION: Applying local vancomycin as an adjunct to SOC in primary TJA is not just cost effective, but cost-saving in reducing PJIs, saving an average of $260.38/patient. Depending on individual institution/practice infection rates and revision surgery costs, local vancomycin administration for primary TJA should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinArthroplasty, Replacement, KneeArthroplasty, Replacement, HipAnti-Bacterial AgentsProsthesis-Related InfectionsHumansCost-Benefit AnalysisPowdersCost SavingsDecision Trees

Stichwörter der Autor:innen

ArthroplastyCostPowderTopicalVancomycin

Substanzen

VancomycinAnti-Bacterial AgentsPowders

Autor:innen und Institutionen

  • Division of Orthopaedic Surgery, University of Toronto, Toronto, Canada. darius.lameire@mail.utoronto.ca.
  • Health Economics and Outcomes Research, Global Market Access, Smith & Nephew, Fort Worth, TX, USA.
  • Division of Orthopaedic Surgery, University of Toronto, Toronto, Canada.
  • Division of Orthopaedic Surgery, St. Michael's Hospital, Toronto, Canada.

Zitieren

APA

Lameire, D. L., Askew, N., Multani, I., Hoit, G., Khoshbin, A., Nherera, L. M., & Atrey, A. (2025). Intra-wound vancomycin powder is cost-saving in primary total hip and knee arthroplasty. International Orthopaedics. https://doi.org/10.1007/s00264-025-06501-8

Vancouver

Lameire DL, Askew N, Multani I, Hoit G, Khoshbin A, Nherera LM, et al. Intra-wound vancomycin powder is cost-saving in primary total hip and knee arthroplasty. International Orthopaedics. 2025. doi:10.1007/s00264-025-06501-8

BibTeX
@article{Lameire2025,
  author = {Lameire, Darius L and Askew, Neil and Multani, Iqbal and Hoit, Graeme and Khoshbin, Amir and Nherera, Leo M and Atrey, Amit},
  title = {Intra-wound vancomycin powder is cost-saving in primary total hip and knee arthroplasty},
  journal = {International Orthopaedics},
  year = {2025},
  doi = {10.1007/s00264-025-06501-8}
}
Kostenlos starten →